Panacea

Panacea fills a real gap in regulatory consulting: the friction of hourly billing and slow manual work. By pairing ex-FDA experts with custom AI tools, they compress timelines and align incentives through milestone-based payments. The 60% faster claim is ambitious but plausible given AI's ability to handle document drafting and predicate research. Where Panacea shines is for startups and mid-size companies that lack deep regulatory bench strength. If you need a 510(k) or De Novo submission and want predictable costs, the milestone model reduces financial risk. The free consultation is a sensible entry point. However, Panacea is not for teams wanting to DIY regulatory work or those strictly budget-constrained for small projects. The lack of transparent pricing tiers means you can't evaluate cost without a call. Competitors like Greenlight Guru and regulatory consultants with flat-fee models exist, but none combine their specific AI toolkit and ex-FDA staff in one package. In practice, we'd recommend Panacea for companies with a clear product and a need for speed, but not for those who prefer a pay-as-you-go SaaS platform or want to keep regulatory work in-house. Real-world caveat: the AI is a tool, not a replacement — the human team remains the key value. If you're okay with a consulting engagement, this is a unique offering.